Cml Healthcare (NYSE:CLC)'s stock had its "market perform" rating reissued by stock analysts at Oppenheimer in a report issued on Monday. Shares of Cml Healthcare (NYSE:CLC) traded up 0.37% on Monday, hitting $65.49. The stock had a trading volume of 51,153 shares. Cml Healthcare has a one year low of $54.16 and a one year […]This article (Cml Healthcare Stock Rating Reaffirmed by Oppenheimer (CLC)) was originally developed by and is property of American Banking News.Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
